Novo sues Lilly over marketing of insulin cartridges:
This article was originally published in Clinica
Executive Summary
Danish company Novo Nordisk, the world's largest insulin producer, is suing its main rival, US company Eli Lilly. Novo alleges that Lilly is marketing its human insulin cartridges in packaging containing misleading statements which was giving users the impression that Novo had approved the use of Lilly cartridges in its pens.